Nanjing Vishee Medical Technology Co Ltd (688580) - Total Liabilities
Based on the latest financial reports, Nanjing Vishee Medical Technology Co Ltd (688580) has total liabilities worth CN¥103.07 Million CNY (≈ $15.08 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Nanjing Vishee Medical Technology Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Nanjing Vishee Medical Technology Co Ltd - Total Liabilities Trend (2013–2025)
This chart illustrates how Nanjing Vishee Medical Technology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Nanjing Vishee Medical Technology Co Ltd to evaluate the company's liquid asset resilience ratio.
Nanjing Vishee Medical Technology Co Ltd Competitors by Total Liabilities
The table below lists competitors of Nanjing Vishee Medical Technology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Guangzhou Grandbuy Co Ltd
SHE:002187
|
China | CN¥3.16 Billion |
|
JINXIN FERT.GRP HD-00001
F:3NX
|
Germany | €4.76 Billion |
|
Floridienne
BR:FLOB
|
Belgium | €625.88 Million |
|
Shanghai GuAo Electronic Technology Co Ltd
SHE:300551
|
China | CN¥115.69 Million |
|
Arvind Fashions Limited
NSE:ARVINDFASN
|
India | Rs30.55 Billion |
|
Foshan Nationstar Optoelectronics Co Ltd
SHE:002449
|
China | CN¥2.30 Billion |
|
Shanghai Conglin Environmental Protection Technology Co. Ltd. A
SHG:688370
|
China | CN¥479.28 Million |
Liability Composition Analysis (2013–2025)
This chart breaks down Nanjing Vishee Medical Technology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Nanjing Vishee Medical Technology Co Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nanjing Vishee Medical Technology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nanjing Vishee Medical Technology Co Ltd (2013–2025)
The table below shows the annual total liabilities of Nanjing Vishee Medical Technology Co Ltd from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥216.00 Million ≈ $31.61 Million |
+11.98% |
| 2024-12-31 | CN¥192.90 Million ≈ $28.23 Million |
+7.60% |
| 2023-12-31 | CN¥179.27 Million ≈ $26.23 Million |
+15.16% |
| 2022-12-31 | CN¥155.67 Million ≈ $22.78 Million |
+47.30% |
| 2021-12-31 | CN¥105.68 Million ≈ $15.46 Million |
-18.36% |
| 2020-12-31 | CN¥129.45 Million ≈ $18.94 Million |
-13.32% |
| 2019-12-31 | CN¥149.35 Million ≈ $21.86 Million |
+33.11% |
| 2018-12-31 | CN¥112.20 Million ≈ $16.42 Million |
+20.46% |
| 2017-12-31 | CN¥93.15 Million ≈ $13.63 Million |
+80.83% |
| 2016-12-31 | CN¥51.51 Million ≈ $7.54 Million |
+151.36% |
| 2015-12-31 | CN¥20.49 Million ≈ $3.00 Million |
+4.03% |
| 2014-12-31 | CN¥19.70 Million ≈ $2.88 Million |
-39.74% |
| 2013-12-31 | CN¥32.69 Million ≈ $4.78 Million |
-- |
About Nanjing Vishee Medical Technology Co Ltd
Nanjing Vishee Medical Technology Co., Ltd provides rehabilitation meditation products and solutions in China and internationally. The company offers MagNeuro, a transcranial magnetic stimulation (TMS) device, and MagNeuro ONE, a TMS therapy system with navigation for psychiatric and neurological applications. It also provides MagBelle, a pelvic floor muscle stimulator for the treatment of urinar… Read more